Tag Archives: Onco360

Specialty Pharmacy News Roundup: December 2023

The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends

Biologics by McKesson and Onco360 Selected as Specialty Pharmacy Partners for Fruzaqla, Ogsiveo, and Truqap

Biologics by McKesson and Onco360 Selected as Specialty Pharmacy Partners for Fruzaqla, Ogsiveo, and Truqap

Takeda Selects Specialty Pharmacy Partners for ADZYNMA and FRUZAQLA

Takeda Pharmaceuticals Selects Specialty Pharmacy Partners for new FDA-approved drugs ADZYNMA and FRUZAQLA

Specialty Pharmacy News Roundup: April 2023

The latest in specialty pharmacy news and research. Stay up to date on companies and industry trends at the forefront of the specialty pharmacy industry. 

Specialty Pharmacy News Roundup: March 2023

AMI’s Specialty Pharmacy Database continually monitors and tracks all limited and exclusive pharmacy distribution agreements

Specialty Pharmacy Limited Distribution Drug Agreements at Year-End 2022

The leading specialty pharmacies were busy signing limited distribution drug agreements at the end of 2022. Here’s a round-up of the activities

Onco360 Selected as Pharmacy Partner for Tibsovo and ORGOVYX®

Onco360, the nation’s largest independent Oncology Pharmacy and clinical support services company, was recently selected to be the pharmacy partner for Tibsovo and ORGOVYX®

Jennifer Yowler Named President of PharMerica Corporation

PharMerica, a subsidiary of BrightSpring Health Services, is a national leader in pharmacy services, serving partners in over 3,100 long-term care, senior living, IDD/behavioral health, home infusion, specialty, and hospital management programs with 160+ local pharmacies